Minireviews
Copyright ©The Author(s) 2020.
World J Gastroenterol. May 14, 2020; 26(18): 2166-2176
Published online May 14, 2020. doi: 10.3748/wjg.v26.i18.2166
Table 1 Main virological and biochemical features in the different clinical phases of chronic hepatitis B in HBsAg+ patients
Phase 1: Immune tolerantPhase 2: Immune activePhase 3: Asymptomatic carrierPhase 4: HBV reactivation
HBeAg+Attempt to remove HBeAgHBeAg-HBeAg+ or -
HBV-DNA ≥ 108 IU/mLHBV-DNA ↓HBV-DNA < 2000 IU/mLHBV-DNA ↑
Normal LFTs→ no damageAltered LFTs→ damageNormal LFTs→ no damageAltered LFTs→ damage